Clinical Laboratory Services Market Size By Test Type (Human & Tumor Genetics, Clinical Chemistry {Routine Chemistry Testing, Specialized Chemistry Testing, Therapeutic Drug Monitoring (TDM) Testing, Endocrinology Chemistry Testing}, Medical Microbiology & Cytology, Other Esoteric Test), By Service Provider (Hospital-based Laboratories, Stand-alone Laboratories, Clinic-based Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

Published Date: Dec 2020  |  Report ID: GMI807  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 165   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Clinical Laboratory Services Market size valued at USD 249.3 billion in 2019 and is expected to grow at over 3.9% CAGR between 2020 and 2026. Rising geriatric population pool that is prone to various chronic conditions in developed as well as developing countries has stimulated the market demand.
 

Clinical Laboratory Services Market

Get more details on this report - Request Free Sample PDF
 

The COVID-19 pandemic will have a moderate to high impact on the global clinical laboratory services market. COVID-19 infection is a respiratory disease and has affected millions of lives around the globe. Increasing cases of COVID-19 infected patients across the globe has led to a rise in clinical chemistry services, especially in specialized chemistry testing segment. Laboratory testing demands have increased significantly and continues to grow at a staggering rate to keep pace with suspected cases of COVID-19, thus boosting the market revenue.
 

Growing awareness among people regarding disease management and early diagnosis

Growing awareness among people regarding disease management along with early diagnosis will fuel the industry growth. Availability of probable cure required for disease state coupled with advancements in tests will increase the demand for clinical tests. Moreover, emerging infectious ailments have the potential to cause substantial mortality, morbidity, and economic damage. Efforts undertaken for the prevention of emerging infectious ailments will further drive the market demand.
 

Clinical Laboratory Services Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: USD 249.3 Billion
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: 3.9% 2026 Value Projection: USD 426.2 Billion
Pages: 165 Tables, Charts & Figures: 193
Geographies covered (15): U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, India, Australia, Brazil, Mexico, South Africa, Saudi Arabia
Segments covered: Test Type, Service Provider and Region
Companies covered (15): Arup Laboratories Inc, Clinical Reference Laboratory, Inc., Sonic Healthcare, Neogenomics Laboratories, Inc. (Neogenomics, Inc.), Opko Health, Inc. (Bioreference Laboratories, Inc.), Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Inc., Fresenius Medical Care (Spectra Laboratories), Qiagen .N.V., Synlab International GmbH, Charles River Laboratories, Fullerton Healthcare Corporation Limited, LifeLabs, Mayo Foundation for Medical Education and Research, Eurofins Scientific
Growth Drivers:
  • Increasing prevalence of target diseases globally
  • Worldwide rising demand for early disease detection
  • Introduction of innovative solutions
  • Growing elderly population base in developed countries
Pitfalls & Challenges:
  • Presence of ambiguous regulatory framework
  • Inadequate reimbursements

Get more details on this report - Request Free Sample PDF
 

Inadequate reimbursements rates may potentially restrain the market growth

Reimbursement rates associated with diagnostic lab tests vary widely and may potentially restrain the clinical laboratory services industry expansion. One of the most common methods to control expenses of laboratory services is to reduce the reimbursement rate. This method can be effective in short run however, it has several disadvantages including irreducible cost to conduct any test, restricting the market growth to some extent.
 

Growing number of cancer patients in U.S will increase the test adoption

Clinical Laboratory Services Market Share By Test Type

Get more details on this report - Request Free Sample PDF
 

The human & tumor genetic segment accounted for a clinical laboratory services market share of 23.7% in 2019. High prevalence of tumors and genetic disorders in pediatric population will upsurge the demand for these tests. For instance, it is estimated that around 174,250 people in the U.S. were diagnosed with leukemia in 2018. This is expected to increase the adoption of tumor testing that will in turn aid in the market size expansion. Also, analytical instruments have been developed that quantifies leukemia cancer and accurate diagnostic decisions enable better surgical performance.
 

Technologically advanced devices utilized for diagnosing diseases in stand-alone laboratories

Stand-alone laboratories segment size was around USD 103.5 billion in 2019 and is poised to show significant growth of 4.4% during the forecast timeframe. Increasing prevalence of rare genetic disorders will influence the demand for stand-alone laboratories that are well-equipped with technologically advanced medical devices. Esoteric testing enables detection and analysis of rare genes or molecules that are performed routinely in the clinical laboratories and genetic testing centers. Stand-alone laboratories perform testing of genetic diseases and are equipped with automated medical devices that aid in accurate and efficient detection.
 

Increasing prevalence of chronic disease among geriatric population in North America

Clinical Laboratory Services Market By Region

Get more details on this report - Request Free Sample PDF
 

North America clinical laboratory services market dominated over 38.9% revenue share in 2019 owing to increasing geriatric population suffering from chronic diseases. Elderly population in age group of 65 years and above suffer from chronic illness such as cancer and viral, bacterial, and fungal infections that will accelerate the demand for clinical laboratory test. Additionally, as per the Canadian Cancer Statistics, around 200,000 Canadians suffered from cancer and 80,000 died in 2017. This has led to an increase in adoption of various test that detect cancer. Furthermore, rising healthcare expenditure and fund accumulations in public healthcare system will escalate the regional market growth.
 

Adoption of business strategies will pave growth opportunities for companies operating in the market

Prominent market players operating in the industry include Fresenius Medical Care, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, and Eurofins Scientific. Acquisition, partnerships and collaboration are the most commonly adopted business strategies to sustain market position.
 

Some of the recent industry developments:

  • In September 2020, LabCorp announced strategic partnership with Infirmary Health to broaden laboratory services across healthcare systems in Alabama. This will lead to business expansion of the company in the region. Such collaborative initiatives will help the organization in the development of patient service centers.
     
  • In September 2020, Rocky Mountain Analytical, a subsidiary of LifeLabs, partnered with Genova Diagnostics aimed to enhance accessibility and affordability of Genova’s diagnostic testing for Canadian population. This collaboration will help the organization to broaden its customer base.
     

The clinical laboratory services market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

Market, By Test Type

  • Human & tumor genetics
  • Clinical chemistry
    • Routine chemistry testing
    • Specialized chemistry testing
    • Therapeutic drug monitoring (TDM) testing
    • Endocrinology chemistry testing
    • Other clinical chemistry testing
  • Medical microbiology & cytology
  • Other esoteric tests

Market, By Service Provider

  • Hospital-based laboratories
  • Stand-alone laboratories
  • clinic-based laboratories

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
       

Frequently Asked Questions (FAQ) :

The industry share of clinical laboratory services was over USD 249.3 billion in 2019 and is anticipated to record more than 3.9% CAGR through 2026.
With the increased prevalence of tumors and genetic disorders among pediatric patients, the human and tumor genetic segment held over 23.7% market share in 2019.
The stand-alone labs reached USD 103.5 billion in 2019 and will register over 4.4% CAGR up to 2026 owing to the availability of advanced & automated medical devices.
North America held around 38.9% industry revenue share in 2019 with the rising number geriatric population prone to chronic diseases like cancer and viral infections.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Dec 2020
  • Pages: 165
  • Tables: 163
  • Charts / Figures: 30
  • Companies covered: 15
  • Countries covered: 15

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X